25.85
price up icon0.31%   0.08
after-market アフターアワーズ: 25.60 -0.25 -0.97%
loading
前日終値:
$25.77
開ける:
$25.48
24時間の取引高:
1.76M
Relative Volume:
0.45
時価総額:
$19.20B
収益:
$956.00K
当期純損益:
$-221.32M
株価収益率:
-80.78
EPS:
-0.32
ネットキャッシュフロー:
$-142.25M
1週間 パフォーマンス:
+8.29%
1か月 パフォーマンス:
-22.21%
6か月 パフォーマンス:
+36.05%
1年 パフォーマンス:
+498.38%
1日の値動き範囲:
Value
$25.12
$26.17
1週間の範囲:
Value
$22.85
$26.85
52週間の値動き範囲:
Value
$2.10
$36.91

Summit Therapeutics Inc Stock (SMMT) Company Profile

Name
名前
Summit Therapeutics Inc
Name
セクター
Healthcare (1173)
Name
電話
305-203-2034
Name
住所
601 BRICKELL KEY DRIVE, MIAMI
Name
職員
159
Name
Twitter
@summitplc
Name
次回の収益日
2025-02-24
Name
最新のSEC提出書
Name
SMMT's Discussions on Twitter

SMMT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SMMT
Summit Therapeutics Inc
25.85 17.73B 956.00K -221.32M -142.25M -0.32
Biotechnology icon
ONC
Beigene Ltd Adr
241.43 27.03B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
436.00 112.64B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.335 40.86M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
588.34 64.17B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
75.06 6.07B 0 -153.72M -103.81M -2.00

Summit Therapeutics Inc Stock (SMMT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-26 アップグレード Citigroup Neutral → Buy
2025-03-21 開始されました Cantor Fitzgerald Overweight
2025-03-12 開始されました Evercore ISI Outperform
2025-02-28 開始されました Goldman Buy
2025-01-08 開始されました Truist Buy
2024-12-11 開始されました Wells Fargo Overweight
2024-12-06 開始されました Jefferies Buy
2024-11-04 開始されました JMP Securities Mkt Outperform
2024-09-27 ダウングレード Citigroup Buy → Neutral
2024-08-12 開始されました H.C. Wainwright Buy
2024-05-07 開始されました Citigroup Buy
2024-03-26 開始されました Stifel Buy
2018-06-28 ダウングレード Janney Buy → Neutral
2018-05-02 開始されました Janney Buy
2018-04-12 繰り返されました Needham Buy
2018-02-13 開始されました BTIG Research Buy
2018-01-04 開始されました SunTrust Buy
2017-12-01 再開されました H.C. Wainwright Buy
2016-11-16 繰り返されました RBC Capital Mkts Outperform
2016-10-05 繰り返されました Needham Buy
2016-09-16 開始されました H.C. Wainwright Buy
2015-03-30 開始されました Needham Buy
2015-03-30 開始されました Oppenheimer Outperform
すべてを表示

Summit Therapeutics Inc (SMMT) 最新ニュース

pulisher
May 24, 2025

3 High-Flying Stocks That Could Soar Even More - Nasdaq

May 24, 2025
pulisher
May 22, 2025

Summit Therapeutics (NasdaqGM:SMMT) Reports US$63M Net Loss For Q1 2025 - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

Summit Therapeutics (SMMT) Receives Buy Rating and $33 Target | - GuruFocus

May 22, 2025
pulisher
May 21, 2025

Summit Therapeutics (SMMT) Receives Buy Rating from Clear Street - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 - The Globe and Mail

May 21, 2025
pulisher
May 19, 2025

Summit Therapeutics reports inducement grants - Medical Buyer

May 19, 2025
pulisher
May 18, 2025

Got $100? 3 Top Growth Stocks to Buy That Could Double Your Money - Yahoo Finance

May 18, 2025
pulisher
May 16, 2025

(SMMT) Trading Report - news.stocktradersdaily.com

May 16, 2025
pulisher
May 16, 2025

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listi - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | SMMT Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

May 16, 2025
pulisher
May 15, 2025

BioNTech says bispecific antibody BNT327 is competitive against Summit's ivonescimab (BNTX:NASDAQ) - Seeking Alpha

May 15, 2025
pulisher
May 14, 2025

Dimensional Fund Advisors LP Acquires 160,592 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) - Defense World

May 14, 2025
pulisher
May 13, 2025

Summit Therapeutics Inc. (NASDAQ:SMMT) Receives $37.40 Consensus PT from Analysts - Defense World

May 13, 2025
pulisher
May 12, 2025

Hsbc Holdings PLC Invests $188,000 in Summit Therapeutics Inc. (NASDAQ:SMMT) - Defense World

May 12, 2025
pulisher
May 11, 2025

Shareholders that lost money on Summit Therapeutics Inc.(SMMT) should contact Levi & Korsinsky about Securities Fraud InvestigationSMMT - ACCESS Newswire

May 11, 2025
pulisher
May 11, 2025

Summit Therapeutics (NASDAQ:SMMT) Upgraded at TD Cowen - Defense World

May 11, 2025
pulisher
May 10, 2025

Shareholders that lost money on Summit Therapeutics Inc. (SMMT) should contact Levi & Korsinsky about Securities Fraud InvestigationSMMT - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Summit Therapeutics Q1 2025 slides: Strong cash position supports advancing Ivonescimab pipeline - Investing.com Canada

May 10, 2025
pulisher
May 09, 2025

SMMT ALERTLevi & Korsinsky Has Commenced an Investigation on Behalf of Summit Therapeutics Inc. Shareholders Who Lost Money - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

Why Recursion Pharmaceuticals Stock Plummeted 24% This Week - The Motley Fool

May 09, 2025
pulisher
May 09, 2025

Summit Therapeutics Inc. (SMMT): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey

May 09, 2025
pulisher
May 08, 2025

Summit Therapeutics (SMMT) Receives Positive Coverage from TD Co - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Summit Therapeutics (SMMT) Receives Positive Coverage from TD Cowen | SMMT Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Summit Therapeutics stock rating upgraded to Buy at TD Cowen By Investing.com - Investing.com India

May 08, 2025
pulisher
May 08, 2025

Summit Therapeutics stock rating upgraded to Buy at TD Cowen - Investing.com

May 08, 2025
pulisher
May 07, 2025

Can Summit Therapeutics Stock Double Your Money? - Nasdaq

May 07, 2025
pulisher
May 06, 2025

Wall Street Analysts Predict a 33.4% Upside in Summit Therapeutics (SMMT): Here's What You Should Know - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

(SMMT) Trading Advice - news.stocktradersdaily.com

May 06, 2025
pulisher
May 04, 2025

Summit Therapeutics Retail Traders Stoked As Stock Surges On Promising Cancer Drug Trial - MSN

May 04, 2025
pulisher
May 04, 2025

Summit Therapeutics Q1 Loss Narrower Than Expected, Sales Nil - MSN

May 04, 2025
pulisher
May 04, 2025

Why Summit Therapeutics Inc. (SMMT) Soared Last Week - Insider Monkey

May 04, 2025
pulisher
May 04, 2025

These 10 Firms Soared Last Week, Here’s Why - Insider Monkey

May 04, 2025
pulisher
May 03, 2025

Summit Therapeutics outlines ivonescimab progress with key Phase III data expected mid-2025 - MSN

May 03, 2025
pulisher
May 02, 2025

Summit Therapeutics (SMMT) Stock: Goldman Sachs Raises Price Target | SMMT Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Summit Therapeutics: Promising Clinical Developments and Financial Stability Drive Buy Rating - TipRanks

May 02, 2025
pulisher
May 02, 2025

Decoding Summit Therapeutics Inc (SMMT): A Strategic SWOT Insigh - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2025 Earnings Call Transcript - Insider Monkey

May 02, 2025
pulisher
May 02, 2025

This Soaring Stock Just Delivered More Good News. Time to Buy? - The Globe and Mail

May 02, 2025
pulisher
May 02, 2025

Summit Therapeutics (SMMT) Advances with Ivonescimab in Key Tria - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Summit Therapeutics Reports Q1 2025 Progress and Financials - TipRanks

May 02, 2025
pulisher
May 02, 2025

Summit Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 02, 2025
pulisher
May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025
pulisher
May 01, 2025

Summit Therapeutics (SMMT) Beats Q1 Earnings Expectations - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Summit Therapeutics Inc Reports Q1 2025 EPS of $(0.09), Aligning with Estimates; Revenue Unreported - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Summit Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 01, 2025
pulisher
May 01, 2025

Summit Therapeutics Reports Financial Results and Operational Pr - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2025 | SMMT Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2025 - Business Wire

May 01, 2025
pulisher
May 01, 2025

Summit Therapeutics (SMMT) Sees Balanced Options Activity Ahead - GuruFocus

May 01, 2025

Summit Therapeutics Inc (SMMT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.15
price down icon 17.27%
$31.32
price down icon 3.63%
$587.61
price up icon 1.06%
$289.96
price up icon 0.33%
$4.25
price up icon 0.48%
$75.06
price up icon 3.26%
大文字化:     |  ボリューム (24 時間):